Tag:
Epitomics
Latest Headlines
Latest Headlines
Abcam's $155M Epitomics buyout expands antibody business
Bidding to up its game in the antibody business, the U.K.'s Abcam has snapped up California-based Epitomics for $155 million.
Epitomics spins off mAb company Apexigen
Burlingame, CA-based Epitomics has spun off a new biotech called Apexigen, which will focus on developing humanized monoclonal antibodies for treatment of cancer and immuno-disorders. Apexigen was
